Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Asset Utilization Ratio (2016 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed Asset Utilization Ratio for 15 consecutive years, with 0.62 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 29.82% to 0.62 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.62 through Dec 2025, up 29.82% year-over-year, with the annual reading at 0.65 for FY2025, 15.5% up from the prior year.
  • Asset Utilization Ratio hit 0.62 in Q4 2025 for Ani Pharmaceuticals, up from 0.6 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.62 in Q4 2025 to a low of 0.28 in Q4 2021.
  • Historically, Asset Utilization Ratio has averaged 0.46 across 5 years, with a median of 0.49 in 2023.
  • Biggest five-year swings in Asset Utilization Ratio: plummeted 38.35% in 2021 and later soared 57.73% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.28 in 2021, then soared by 51.68% to 0.42 in 2022, then rose by 28.56% to 0.54 in 2023, then dropped by 11.95% to 0.48 in 2024, then grew by 29.82% to 0.62 in 2025.
  • Business Quant data shows Asset Utilization Ratio for ANIP at 0.62 in Q4 2025, 0.6 in Q3 2025, and 0.57 in Q2 2025.